
PHGDH-inactive
CAS No. 1914971-16-6
PHGDH-inactive( —— )
Catalog No. M27683 CAS No. 1914971-16-6
PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | Get Quote |
![]() ![]() |
5MG | 68 | Get Quote |
![]() ![]() |
10MG | 120 | Get Quote |
![]() ![]() |
25MG | 255 | Get Quote |
![]() ![]() |
50MG | 410 | Get Quote |
![]() ![]() |
100MG | 591 | Get Quote |
![]() ![]() |
500MG | 1224 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePHGDH-inactive
-
NoteResearch use only, not for human use.
-
Brief DescriptionPHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
-
DescriptionPHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorhCE2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1914971-16-6
-
Formula Weight327.45
-
Molecular FormulaC17H21N5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (254.48 mM)
-
SMILESCc1cc(C)nc(NC(=S)N2CCN(CC2)c2ccncc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhen-Peng Mai, et al. Biotransformation of alisol G by Penicillium janthinellum and the hCE2 inhibitory effects of its metabolites. Phytochemistry Letters, Volume 13, September 2015, Pages 228–233.
molnova catalog



related products
-
threo-Guaiacylglycer...
Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production.
-
1-(2-Pyridylazo)-2-n...
1-(2-Pyridylazo)-2-naphthol is a complexation index agent.
-
Isorhamnetin 3-O-gal...
Isorhamnetin 3-O-galactoside shows antioxidant, anti-inflammatory, neuroprotective,and barrier protective activities, it could be used as a candidate therapeutic for treatment of severe vascular inflammatory diseases.